Pharmacovigilance – Products
Product News
Completion of Proof of Concept Study for Heart Attack
Animal study demonstrates midkine treatment reduces heart muscle death by 27% following heart attack.
Product News
MetaMap® Tox - A Novel Technology for Early Safety Enablement in Pharmaceutical Development will be Validated by Industry Consortium
Cambridge Healthtech Associates and Metanomics Health GmbH announce a collaborative technology evaluation.
Product News
Roche Joins in Spanish Research Cooperation for Personalized Treatment of Hepatitis B and C
Project aims to identify personalized treatment for each individual while minimizing the healthcare costs and side effects experienced by subjects.
Product News
Bosch at Interpack 2011 Innovations Offer Maximized Quality and Efficiency for Pharmaceutical Lines
Bosch expands its portfolio in syringe processing and pure water generation.
Product News
CIT Launches LeadScreen™, a New Range of Fast, Cost-effective Services for Drug Candidate Selection
Services offer an extensive array of tests designed to give an early evaluation of safety of drugs thought to have development potential.
Product News
Thermo Fisher Scientific Adds New Atlas CDS Software Control for Shimadzu Prominence HPLC
Atlas CDS™ provides chromatographers with a client/server chromatography-based software solution available for controlling multi-vendor instruments.
Product News
Reinnervate to Launch Alvetex® in the United States at the SBS 17th Annual Conference
Company to host technical tutorial on optimizing alvetex® for enhanced 3D cell culture.
Product News
Hepregen Corporation Presents Results of Liver Toxicity Study at Annual Meeting of the Society of Toxicology
Hepregen's microliver platform, HepatoPac™, provides increased confidence in drug development to impact patient safety.
Product News
Theratechnologies Announces New Clinical Program in Muscle Wasting in COPD
Company announces new clinical program by using the Company's lead compound, tesamorelin, a human growth hormone releasing factor analogue.
Product News
Dynavax's Two Phase 3 HEPLISAV Trials Cleared by DSMB to Continue to Study Completion
DSMB established for Dynavax's two ongoing Phase 3 trials for HEPLISAV™ has completed planned safety assessments.
Advertisement